{
  "nodes": [
    {
      "id": "N1",
      "label": "Step 1",
      "customData": {
        "node_id": "A",
        "node_step_index": 0,
        "content": "September 10, 2014: Patient presented with sudden glossolalia and right lower limb numbness and was diagnosed with stage IIIA lung adenocarcinoma.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C34.9",
              "label": "Lung cancer, unspecified",
              "status": "active",
              "onset_date": "2014-09-10"
            }
          ],
          "HPI": [
            {
              "summary": "Patient presented with sudden glossolalia and right lower limb numbness.",
              "onset": "2014-09-10",
              "progression": "sudden",
              "associated_symptoms": [
                "Glossolalia",
                "Numbness"
              ]
            }
          ]
        },
        "timestamp": "2014-09-10"
      }
    },
    {
      "id": "N2",
      "label": "Step 2",
      "customData": {
        "node_id": "B",
        "node_step_index": 1,
        "content": "September 24, 2014: Patient underwent resection of the upper lobe and received pemetrexed combined with carboplatin for four cycles of chemotherapy.",
        "clinical_data": {
          "procedures": [
            {
              "name": "Resection of upper lobe of lung",
              "date": "2014-09-24",
              "location": "lung"
            }
          ],
          "medications": [
            {
              "drug": "pemetrexed",
              "start_date": "2014-09-24",
              "end_date": null,
              "indication": "cancer"
            },
            {
              "drug": "carboplatin",
              "start_date": "2014-09-24",
              "end_date": null,
              "indication": "cancer"
            }
          ]
        },
        "timestamp": "2014-09-24"
      }
    },
    {
      "id": "N3",
      "label": "Step 3",
      "customData": {
        "node_id": "C",
        "node_step_index": 2,
        "content": "November 2015: Disease progressed.",
        "clinical_data": {},
        "timestamp": "2015-11"
      }
    },
    {
      "id": "N4",
      "label": "Step 4",
      "customData": {
        "node_id": "D",
        "node_step_index": 3,
        "content": "November 11, 2015 to March 11, 2016: Patient was given paclitaxel plus cisplatin combined with bevacizumab for six cycles.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C0030372",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": "2015-11-11",
              "end_date": "2016-03-11",
              "indication": null
            },
            {
              "drug": "C0008833",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": "2015-11-11",
              "end_date": "2016-03-11",
              "indication": null
            },
            {
              "drug": "C1263455",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": "2015-11-11",
              "end_date": "2016-03-11",
              "indication": null
            }
          ]
        }
      }
    },
    {
      "id": "N5",
      "label": "Step 5",
      "customData": {
        "node_id": "E",
        "node_step_index": 4,
        "content": "April 1, 2016 to April 26, 2019: Patient received pemetrexed combined with bevacizumab, and his condition remained stable.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C0974184",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": "2016-04-01",
              "end_date": "2019-04-26",
              "indication": null
            },
            {
              "drug": "C1634549",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": "2016-04-01",
              "end_date": "2019-04-26",
              "indication": null
            }
          ]
        }
      }
    },
    {
      "id": "N6",
      "label": "Step 6",
      "customData": {
        "node_id": "F",
        "node_step_index": 5,
        "content": "April 26, 2019: 64-year-old nonsmoking woman visited the hospital for further treatment due to intolerance of side effects from previous chemotherapy for lung adenocarcinoma, including myelosuppression and cardiac and renal insufficiency. Chest CT showed bone metastases in the thoracolumbar spine and bilateral local ribs, nodules in both lungs, and pericardial and left pleural effusion. After the last cycle of treatment with pemetrexed plus bevacizumab, CT showed bone metastases in the thoracolumbar spine and bilateral local ribs, nodules in both lungs, and pericardial and left pleural effusion. NGS analysis showed EGFR G724S [mutant allele frequency (MAF): 67.59%] mutation in exon 18 and R776H (MAF: 40.54%) mutation in exon 20 as well as amplification. Patient was diagnosed with lung adenocarcinoma with rare EGFR G724S and R776H mutations and amplification.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C34",
              "label": "lung adenocarcinoma",
              "status": "active",
              "onset_date": null
            }
          ],
          "imaging": [
            {
              "type": "CT of chest",
              "body_part": "thorax",
              "modality": "CT",
              "finding": "bone metastases in the thoracolumbar spine and bilateral local ribs, nodules in both lungs, and pericardial and left pleural effusion",
              "impression": "bone metastases in the thoracolumbar spine and bilateral local ribs, nodules in both lungs, and pericardial and left pleural effusion",
              "date": "2019-04-26"
            }
          ],
          "medications": [
            {
              "drug": "pemetrexed",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": "lung adenocarcinoma"
            },
            {
              "drug": "bevacizumab",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": "lung adenocarcinoma"
            }
          ],
          "social_history": [
            {
              "category": "smoking",
              "status": "never",
              "description": "nonsmoking"
            }
          ]
        }
      }
    }
  ],
  "edges": [
    {
      "from": "N1",
      "to": "N2",
      "data": {
        "edge_id": "A_to_B",
        "branch_flag": true,
        "content": "Patient underwent resection of the upper lobe and received pemetrexed combined with carboplatin for four cycles of chemotherapy following initial presentation with glossolalia and numbness and diagnosis of lung adenocarcinoma.",
        "transition_event": {
          "trigger_type": "procedure",
          "trigger_entities": [
            "C0035406"
          ],
          "change_type": "addition",
          "target_domain": "procedure",
          "timestamp": "2014-09-24"
        }
      }
    },
    {
      "from": "N2",
      "to": "N3",
      "data": {
        "edge_id": "B_to_C",
        "branch_flag": true,
        "content": "Disease progressed after resection of the upper lobe and four cycles of pemetrexed and carboplatin chemotherapy.",
        "transition_event": {
          "trigger_type": "progression",
          "trigger_entities": [
            "C0012634"
          ],
          "change_type": "progression",
          "target_domain": "diagnosis",
          "timestamp": "2015-11"
        }
      }
    },
    {
      "from": "N3",
      "to": "N4",
      "data": {
        "edge_id": "C_to_D",
        "branch_flag": true,
        "content": "Patient was given paclitaxel plus cisplatin combined with bevacizumab for six cycles following disease progression.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C0030372",
            "C0008833",
            "C1263455"
          ],
          "change_type": "addition",
          "target_domain": "medication",
          "timestamp": "2015-11-11"
        }
      }
    },
    {
      "from": "N4",
      "to": "N5",
      "data": {
        "edge_id": "D_to_E",
        "branch_flag": true,
        "content": "Patient received pemetrexed combined with bevacizumab, and his condition remained stable after treatment with paclitaxel, cisplatin, and bevacizumab.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C0974184",
            "C1634549"
          ],
          "change_type": "other",
          "target_domain": "medication",
          "timestamp": "2016-04-01"
        }
      }
    },
    {
      "from": "N5",
      "to": "N6",
      "data": {
        "edge_id": "E_to_F",
        "branch_flag": true,
        "content": "Patient visited the hospital for further treatment due to intolerance of side effects from previous chemotherapy for lung adenocarcinoma, including myelosuppression and cardiac and renal insufficiency. Chest CT showed bone metastases in the thoracolumbar spine and bilateral local ribs, nodules in both lungs, and pericardial and left pleural effusion. After the last cycle of treatment with pemetrexed plus bevacizumab, CT showed bone metastases in the thoracolumbar spine and bilateral local ribs, nodules in both lungs, and pericardial and left pleural effusion. NGS analysis showed EGFR G724S [mutant allele frequency (MAF): 67.59%] mutation in exon 18 and R776H (MAF: 40.54%) mutation in exon 20 as well as amplification. Patient was diagnosed with lung adenocarcinoma with rare EGFR G724S and R776H mutations and amplification after a period of stable condition on pemetrexed and bevacizumab.",
        "transition_event": {
          "trigger_type": "symptom_onset",
          "trigger_entities": [
            "C0027044",
            "C0007193",
            "C0030699"
          ],
          "change_type": "progression",
          "target_domain": "symptom",
          "timestamp": "2019-04-26"
        }
      }
    }
  ]
}